Alimera Sciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022, and Provide Corporate Update
Alimera Sciences (Nasdaq: ALIM) will report its third quarter financial results on November 14, 2022, before market opening.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alimera Sciences (Nasdaq: ALIM) will report its third quarter financial results on November 14, 2022, before market opening.
A conference call is scheduled for 9:00 AM ET on the same day to discuss the financial results and corporate developments. Participants can pre-register for the call and will receive dial-in details upon registration.
The call will also be accessible via a live webcast, and a replay will be available after the call until February 27, 2023.
Positive
- Scheduled report of Q3 financial results indicates proactive communication with investors.
Negative
- None.
Details
News Market Reaction – ALIM
The recorded move for ALIM in the trading session of this news was +1.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call to be held Monday, November 14, at 9:00am Eastern Time
ATLANTA, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report third quarter financial results on Monday, November 14, 2022, before the market opens.
Management will host a conference call at 9:00 AM ET the same day, to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.
Participants are asked to pre-register for the call.
Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.
The conference call will also be available through a live webcast, which is also available through the company’s website.
A webcast replay of the call will be available approximately one hour after the end of the call through February 27, 2023. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 1728884. The telephonic replay will be available until November 28, 2022.
About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: | For investor inquiries: | |
| Jules Abraham | Scott Gordon | |
| for Alimera Sciences | for Alimera Sciences | |
| 917-885-7378 | scottg@coreir.com | |
| julesa@coreir.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.